Patent · US Active

Modified release compositions of epalrestat or a derivative thereof and methods for using the same

US9566269B2 · kind B2 · utility

0Cited by

46References

21Claims

0Family size

Assignee

BIONEVIA PHARMACEUTICALS, INC. · US

Inventors

Isabel Kalofonos · Cambridge, US
Judy Caron · Westwood, US
William Martin-Doyle · Newton, US

Key dates

Filing date	Jan 20, 2012
Grant date	Feb 14, 2017
Priority date	—
Expiry date	Jan 20, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/1623
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release pharmaceutical compositions of epalrestat are provided. Methods of manufacturing the tablets and treating various diseases and conditions, including diabetes and diabetic complications, by administering the modified release compositions to patients in need thereof are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.